« Previous
Next »
Titles
- Buprenorphine: an overview for clinicians1
- Extended-release opioid agonists and antagonist medications for addiction treatment (MAT) in patients with opioid use disorder: effectiveness and value : final evidence report1
- Increasing access to medications for opioid use disorder: policy strategies during and after COVID-19 pandemic1
- Learning from COVID-19: how pandemic-era policies for methadone prescribing could improve opioid treatment1
- MAT for hospitalized patients1
- MAT in the emergency department: FAQ1
- Management of patients with opioid dependence: a review of clinical, delivery system, and policy options1
- Opioid use disorders: HHS needs measures to assess the effectiveness of efforts to expand access to medication-assisted treatment : report to majority leader, U.S. Senate1
- Show me the money: economic evaluations of opioid use disorder interventions1
- The role of community health centers in addressing the opioid epidemic1
- Why health plans should go to the "MAT" in the fight against opioid addiction1
- [New life, new hope]: [accepting methadone therapy]1